SurModics, Inc. (SRDX)
42.98
+0.00%
SurModics, Inc. (SRDX) is currently trading at $42.98. This represents a gain of 0% from the previous session. With a market capitalization of $0.61B, SRDX is a key component of the Health Care sector. Investors looking to trade SRDX should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus β
T&Cs Apply. Trade SRDX commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: β
- Options: β
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0β$0.005/share
- Fractional Shares: β
- Options: β
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: β
- Options: β
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: β
- Options: β
- Notes: Easy mobile app
AI Market Sentiment
As of today, SurModics, Inc. (SRDX) shows a bullish trend. Analysts are watching the 0.00 level closely.
Fundamentals
Mkt Cap0.61B
P/E Ratio0.0000
Volume0
60-Day Technical Chart
Advanced Charting
Need more indicators for SRDX? Use the world's #1 platform.
Open SRDX on TradingView βCharting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $43
| Metric |
SRDX +0.00% |
INTC +1.65% |
CSGP -8.89% |
AXTI +16.79% |
|---|---|---|---|---|
| Price | $42.98 | $46.88 | $44.78 | $40.97 |
| Mkt Cap | $0.61B | $233.84B | $18.78B | $2.22B |
| - | View β | View β | View β |
Latest Headlines
Surmodics stock rises after FTC indicates no appeal of merger ruling
Investing.com β’ Nov 17, 2025
Surmodics surges after court denies injunction to block sale to GTCR (SRDX:NASDAQ)
Seeking Alpha β’ Nov 11, 2025
Surmodics (SRDX) Surges After Court Clears Path for GTCR Acquisi
GuruFocus β’ Nov 11, 2025
Here's Why You Should Retain Surmodics Stock in Your Portfolio Now
Yahoo Finance β’ Mar 18, 2025
Surmodics Stock Soars Amid Positive Registry Study Results and Court Ruling
StocksToTrade β’ Nov 11, 2025
β Gemini Agentic AI Analyst Insight for SRDX
Market Education
- Penny Stock List Nov 19, 2023
- I want to day trade, which technical analysis indicators work best. Jul 15, 2023
- October Market Volatility: Why Investors Fear the βDanger Monthβ Sep 26, 2025
External Research